Skip to main content

loteprednol etabonate

NDC 60219-1367 · Amneal Pharmaceuticals NY LLC

Generic nameloteprednol etabonate
Dosage formSUSPENSION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)LOTEPREDNOL ETABONATE
Strength2 mg/mL
Pharmacologic classCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
Marketing categoryANDA

Packages

60219-1367-6 — 1 BOTTLE in 1 CARTON (60219-1367-6) / 10 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

24208-299 — loteprednol etabonate, 24208-353 — loteprednol etabonate, 24208-358 — loteprednol etabonate and tobramycin, 24208-443 — loteprednol etabonate, 24208-503 — loteprednol etabonate, 24208-507 — loteprednol etabonate, 24208-508 — loteprednol etabonate, 46708-801 — Loteprednol etabonate and Tobramycin, 60219-1362 — loteprednol etabonate, 60219-1366 — loteprednol etabonate, 62332-801 — Loteprednol etabonate and Tobramycin, 62756-232 — Loteprednol Etabonate, 70244-034 — Loteprednol Etabonate, 70244-035 — Loteprednol Etabonate, 70244-036 — Loteprednol Etabonate, 70748-300 — loteprednol etabonate, 71571-121 — loteprednol etabonate, 71571-333 — loteprednol etabonate, 72485-630 — Loteprednol Etabonate, 72485-653 — Loteprednol Etabonate, +10 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels